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Aims Recording and analysing impedance ﬂuctuation along the cardiac cycle in the right (RV) and left ventricles (LV).
Methods
and results
During a biventricular (BiV) implantation procedure, impedance was sequentially derived between the atrial ring elec-
trode and either electrode (tip or ring) of the RV lead [transvalvular impedance (TVI)], and between the atrial ring
and either the tip or ring electrode of a coronary sinus lead, positioned in a cardiac vein [left ventricle impedance
(LVI)]. The LVI signal was also recorded by the implanted pacemaker at the 1 day and 3 months follow-ups. With
intrinsic conduction, TVI showed an average increase of 53+29 V during ventricular systole, whereas at the
same time, LVI decreased by 45+21 V (25 and 23 patients, respectively, out of 28 tested cases). Transvalvular impe-
dance and LVI displayed a similar time course, which appeared to be related to the systolic timing in the RV and LV.
Both LVI amplitude and duration decreased as a function of the cardiac rate. The LVI deﬂection started immediately
after LV stimulation, and often anticipated the R-wave sensing after contralateral pacing. At the 3-month follow-up,
LVI amplitude was decreased in 70% of cases and increased in the remainder, with a non-signiﬁcant average change of
25+85% with respect to the acute recordings.
Conclusion Transvalvular impedance properties are consistent with the assumption of an inverse relationship with RV volume.
Though LVI requires a different physical interpretation, the waveform duration might reﬂect the timing of LV myo-
cardial contraction. In this hypothesis, the relationship between TVI and LVI could provide insight into the effects of
BiV pacing on mechanical synchronization.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Biventricular (BiV) pacing is widely acknowledged as a valuable
approach to the treatment of heart failure complicated by left ven-
tricular conduction delay.
1 The essential aim of this pacing therapy
is the correction of ventricular dyssynchrony, thus improving systo-
lic and diastolic function.
2,3 This can in turn induce a process of
reverse myocardial remodelling, leading eventually to chronic
structural beneﬁts.
4,5 In order to increase the chance of a positive
response to the treatment, stimulation sites and timing should be
chosen with the aim of optimizing the mechanical aspects of
inter- and intra-ventricular synchronization,
6 which are usually
assessed by complex and time-consuming echocardiographic tech-
niques before and after the implantation.
7 However, it would be
preferable to obtain information on the intrinsic and paced mech-
anical activity of the heart when the implantation procedure is in
progress, so that the location of the leads could be modiﬁed if
the acute effects of BiV stimulation were not satisfactory.
Cardiac impedance recording represents an interesting option
to detect changes in ventricular mechanics without the use of
echocardiography. Cardiac impedance can be measured with stan-
dard pacing electrodes as soon as they are positioned and is
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along the cardiac cycle.
8 Several methods have been developed to
record impedance ﬂuctuation in the right ventricle (RV), including
unipolar, bipolar and transvalvular impedance (TVI).
9–11 Although
RV impedance has been extensively studied, little is known at
present on impedance changes produced by the activity of the left
ventricle (LV). The present study was designed to address this
issue, characterizing the impedance signal detected by a coronary
sinus lead inserted in a cardiac vein for transvenous LV stimulation.
Methods
The study was carried out in 28 patients with standard indications for
BiV pacing, undergoing the implantation of a three-chamber pacemaker
equipped for high-resolution impedance recording (Helios 300,
Medico, Italy). The J-shaped atrial lead was positioned in the right
appendage; the RV lead was positioned in the mid-low septum by
active ﬁxation (screw-in); the LV lead was positioned in a posterolat-
eral vein in 21 cases and in the inferolateral vein in 7 cases. Pre-shaped
or linear, bipolar or unipolar LV leads of different manufacturers were
used, according to the anatomy of each patient. In all cases but one,
lead insertion was performed through the left subclavian vein.
Acute impedance recording was obtained on implantation, using a
dedicated external device with 1 kHz sampling rate. The impedance
ﬂuctuation was ﬁrst derived in RV with transvalvular conﬁguration
(TVI), i.e. between the ring electrode of the atrial lead and either
the ring or the tip electrode of the RV lead. In the second step, impe-
dance was recorded between the atrial ring electrode and either the
tip or the ring of the LV lead [left ventricle impedance (LVI)], and
between the same LV electrode and a steel retractor put in contact
with the patient’s skin in the left-pectoral region. Then, the atrial con-
tribution to the TVI and LVI signals was assessed by recording the
impedance between the atrial ring electrode and the patient’s skin
[right atrium impedance (RAI)]. Transvalvular impedance, LVI, and
RAI waveforms were all recorded with intrinsic atrioventricular con-
duction (AVC). In addition, TVI and RAI were recorded during RV
pacing, and LVI with pacing in the LV. After the series of acute
measurements, the LV lead was permanently connected to the impe-
dance detector of the implanted pacemaker. LVI was assessed on the
ﬁrst day after implantation and the next monitoring session at 3-month
follow-up. The impedance signal was sampled at 60 Hz and transmitted
to the pacemaker programmer by real-time telemetry. LVI was
recorded during intrinsic AVC and unilateral stimulation in RV and
LV, as well as with synchronous BiV pacing.
The study complies with the Helsinki declaration and was approved
by the local Ethics Committee. All patients provided informed consent.
Both acute and chronic impedance measurements were performed
with DC coupling. All recordings were stored in digital form and ana-
lysed off-line by means of standard software (AcqKnowledge, BIOPAC
Systems and Microsoft Excel 2000). Data are reported as mean+
standard deviation. The statistical signiﬁcance of differences has been




Transvalvular impedance was recorded with RV ring or RV tip
electrodes in 14 and 11 cases, respectively, choosing the electrode
conﬁguration in order to maximize the signal-to-noise ratio in each
patient. In both instances, TVI recorded with intrinsic AV conduc-
tion increased during the ventricular systole and decreased back to
the baseline in diastole, starting from the decay phase of the
T-wave (Figure 1A). The cyclical TVI excursion ranged from 17 to
98 V in different patients. Table 1 reports the average amplitude
of the TVI waveform in the patient group, and the average time
................................................................................
Table 1 Impedance signals with intrinsic
atrioventricular conduction
TVI LVI RAI
Systolic excursion (V)5 3 +29 245+21 1+2
Reversal time (ms) 432+93 431+68 n.d.
The signal reversal time corresponds to the time interval from R-wave sensing in
RVand LV to the start of impedance decay (TVI) or recovery (LVI). The parameter
was not detectable (n.d.) for RAI.
Figure 1 From top to bottom tracings: atrial electrogram, ven-
tricular electrogram, impedance waveform, surface ECG (III). The
ventricular input was derived from the right ventricular tip elec-
trode in (A), and the left ventricular ring electrode in (B). Each
panel shows the average signals over 10 consecutive cardiac
cycles. The two sets of tracings were recorded in sequence
and have been synchronized by taking the QRS complex as the
common time reference. The transvalvular impedance (TVI)
waveform shown in (A) is characterized by a marked systolic
increase, which was completed at the start of T-wave decay. In
the same phase of the cardiac cycle, LVI was decreased (B).
Note that the gain was doubled for LVI with respect to TVI.
Recording and analysing LV impedance ﬂuctuation 535interval between R-wave detection in RV and the onset of TVI
decline, referred to as the signal reversal time. Three cases
(12%) were not included in the general evaluation, as noisy TVI
signals with an unusual pattern were recorded with both RV ring
and tip electrodes.
VDD pacing with fully evoked QRS complexes entailed a
reduction of TVI amplitude with respect to the value measured
in each patient with intrinsic AVC (216+26%; P , 0.05), and a
non-signiﬁcant prolongation of the signal reversal time (32+
74 ms). In some cases, the paced waveform also showed morpho-
logical modiﬁcations and more than one peak could be noticed in
the Q-T interval. Nevertheless, the maximum TVI peak always
occurred in telesystole, followed by a phase with negative slope
in diastole.
LVI waveform
LVI was recorded with LV ring or LV tip electrodes in 10 and 13
cases, respectively. With any electrode conﬁguration and ventricu-
lar activation modality (intrinsic AVC or LV stimulation), all implan-
tations performed in a posterolateral vein showed a marked
impedance decrease during the ventricular systole, followed by a
progressive rise in diastole (Figure 1B). Five cases (18%) implanted
outside the posterolateral region for anatomical constraints,
featured unstable impedance signals heavily affected by respiratory
components, and were therefore excluded from the general evalu-
ation. LVI mean amplitude and reversal time (i.e. the time interval
between R-wave detection in LV and the onset of LVI increase)
measured on implantation with intrinsic AVC, are reported in
Table 1. The peak-to-peak amplitude of the LVI waveform ranged
from 223 to 2110 V in the patient group.
LVI signals recorded with intrinsic AVC and sequential LV stimu-
lation are compared in Figure 2. The systolic decrease in LVI started
immediately after the pacing spike or the R-wave detection in the
LV, which generally occurred in the late phase of the QRS
complex. In all cases, switching the activation pattern from intrinsic
AVC to LV stimulation produced some changes in the LVI wave-
form. In particular, the paced signal showed a reduced amplitude
(219+13%; P , 0.05) and a slower time course, due to
delayed impedance return to baseline (72+65 ms; P , 0.05).
The LVI waveform derived by the implanted pacemaker right
after implantation fully corresponded to the signal recorded in
the same patient by the external device and remained essentially
stable for some hours (Table 2). In the chronic follow-up, the
signal amplitude was found to be decreased in 70% of cases and
increased in the remaining 30%. On average, LVI amplitude
recorded with intrinsic AVC showed a non-signiﬁcant reduction
to 82+56% and 95+85% of the corresponding acute value,
1 day and 3 months after implantation, respectively.
RAI waveform
The impedance recorded between the atrial ring electrode and the
patient’s skin in the left thorax showed only small changes during
the cardiac cycle, mostly restricted to the time of atrial systole.
Figure 2 From top to bottom tracings: atrial electrogram, left ventricular electrogram, LVI waveform, surface ECG (I). The ventricular input
was derived from the left ventricular tip electrode with intrinsic atrioventricular conduction (left-hand panel) and VDD pacing with 80 ms atrio-
ventricular delay (right). Left ventricular stimulation applied in the posterolateral region induced a mild decrease in the amplitude of LVI wave-
form and a slower impedance recovery.
................................................................................
Table 2 Post-implant modiﬁcation in LVI waveform




2112+12 2116+13 2108+9 290+7*
Reversal
time (ms)
590+17 566+14* 521+18* 497+17*
LVI signals with intrinsic atrioventricular conduction. Data from a single patient
showing the progressive shortening of the reversal time, and a signiﬁcant decrease
in LVI amplitude at 1-day follow-up.
*P , 0.01 vs. the previous step; one-way ANOVA and Student t-test adjusted for
multiple comparisons.
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of TVI and LVI offset, the atrial contribution to the impedance ﬂuc-
tuation taking place during ventricular ejection and passive ﬁlling
was negligible (Table 1).
Factors affecting LVI
LVI signal amplitude and duration were both dependent on the
cardiac rate, decreasing when the rate increased. Table 3 reports
a typical example of the effects of stepwise pacing rate changes
in a patient with VVI stimulation applied in the LV. In addition,
the amplitude of LVI ﬂuctuation was modulated by the adrenergic
input. Figure 3 shows the LVI excursion in individual cardiac beats
as a function of the RR interval in the previous cycle, in a patient
with intermittent AVC of paroxysmal atrial ﬁbrillation. LVI ampli-
tude (reported as absolute value in the graph) lessened with the
decreasing RR interval, at rest as well as in the case of isoproter-
enol administration. In spite of the marked increase in ventricular
rate induced by the adrenergic agonist, data were homogeneously
distributed in the range of RR intervals from 450 to 700 ms (the
mean cycle length within this range was 590+66 and 569+
68 ms, respectively, before and during isoproterenol infusion),
allowing the comparison of LVI signals recorded in both conditions.
If only beats with a cycle length ranging from 450 to 700 ms were
selected, the amplitude of LVI ﬂuctuation proved signiﬁcantly
higher during adrenergic challenge than at rest (240.5+4.9 and
226.8+8.5 V, respectively).
The LVI waveform was also inﬂuenced by the pattern of ventri-
cular activation. In comparison with the signal recorded with intrin-
sic AVC in each patient, the time interval from QRS onset to the
start of the LVI ascending phase was prolonged with RV unilateral
pacing (22+14 ms) and shortened with LV and BiV pacing
(257+47 and 268+60 ms, respectively). All changes were
statistically signiﬁcant with P , 0.05. With contralateral pacing,
the start of LVI negative deﬂection often anticipated the R-wave
detection in the LV.
In contrast, the LVI waveform was not affected by the orien-
tation of the electric ﬁeld through which the impedance was
measured. The signal recorded by an electrode placed in a
postero-lateral cardiac vein did not change at all if the reference
pole was moved from the atrial ring to the patient’s skin in the
implantation area, i.e. from the right to the left side of the thorax.
Discussion
During the ventricular systole, a prominent rise in RV impedance is
consistently detected with different recording techniques, all based
upon the use of endocavitary electrodes of transvenous pacing
leads in unipolar, bipolar, or transvalvular conﬁguration.
8–11 In
most previous reports, RV impedance was measured with ventri-
cular leads positioned in the apical region. However, the present
study shows that similar results can also be obtained by TVI
recording in the mid-low septum. The observation that the main
properties of the TVI signal were not dependent on the location
of the RV electrode involved in impedance sampling and were
maintained if the ring electrode was used instead of the tip, sup-
ports the concept that the systolic rise in TVI could reﬂect the
RV volume decrease occurring in the ejection phase.
8,12 Indeed,
an increase in the total impedance sensed by an electrode
placed inside the ventricle can be predicted whenever the ventri-
cular cross-section is reduced, as the conductivity of the myocar-
dium is lower than that of the blood.
11 In accordance with this
interpretation, TVI started to decline in the last part of the
T-wave, a time compatible with RV myocardial relaxation and
passive ﬁlling, which could well anticipate the LV repolarization
in patients presenting with delayed LV conduction. Moreover, pre-
vious experience demonstrated that the assessment of ventricular
volume inferred from TVI data provided reliable information on
acute changes in the adrenergic tone, allowing a physiological regu-
lation of the pacing rate.
13–15
In the present study, an opposite impedance waveform charac-
terized by a marked reduction in systole was recorded with trans-
venous pacing leads in the LV postero-lateral region. LVI
ﬂuctuation is probably unrelated to LV volume changes, as it
started immediately after LV stimulation, without a pre-ejection
interval. Nevertheless, the close relationship between the onset
of TVI decay in the RV and LVI rise in the LV suggests that the
LVI trend reversal could represent a marker of the end of LV
systole. Consistently, the time course of LVI decrease was shor-
tened by cardiac rate acceleration, which is known to reduce the
systole duration. The amplitude of the LVI waveform was also
....................................................
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Table 3 Effects of cardiac rate on LVI parameters
VVI pacing in LV
45 b.p.m. 80 b.p.m. 100 b.p.m.
Systolic excursion (V) 223.1+1.6 215.6+2.7* 212.1+2.3*
Reversal time (ms) 428+9 396+20* 361+17*
Data refer to a representative single patient. Both parameters decreased
signiﬁcantly as a function of the rate.
*P , 0.01 vs. the previous step; one-way ANOVA and Student t-test adjusted for
multiple comparisons.
Figure 3 Amplitude of LVI ﬂuctuation (absolute values) in
single cardiac beats as a function of the RR interval in the previous
cycle, at basal (green triangles) and during isoproterenol infusion
(red circles), with respective best-ﬁt curves. The basal RR interval
was spread over a wide range, due to intermittent conduction of
atrial ﬁbrillation. Adrenergic stimulation shifted upward the
relationship between LVI amplitude and cycle length.
Recording and analysing LV impedance ﬂuctuation 537sensitive to changes in cardiac activity, decreasing as a function of
pacing rate and related ﬁlling-time reduction, and increasing during
adrenergic stimulation. Indeed, when the basal LVI excursion was
compared with the ﬂuctuation recorded during isoproterenol
administration within the same range of cardiac rate, a clear-cut
increase in the LVI downstroke was demonstrated.
A model to explain LVI generation
At present, the real nature of the LVI signal is just a matter of
speculation. It must be pointed out that, in a three-dimensional
conducting volume where the electric ﬁeld decreases as a function
of the distance from the current source, the largest part of the
total impedance detected by a voltage-sampling electrode is actu-
ally concentrated around the electrode itself. As a result, the impe-
dance changes recorded from a cardiac vein should mainly reﬂect
local modiﬁcations in the conducting medium, rather than events
occurring in remote areas. This principle seems to hold true, as
the LVI signal remained constant when the counter-electrode of
the recording dipole was moved from the atrial ring to the patient’s
skin in the implantation area, that is, the left pectoral region. Only
the LVI offset was affected by the geometric conﬁguration of the
electric ﬁeld, while the impedance ﬂuctuation was unchanged,
suggesting that the waveform was fully modulated by phenomena
taking place in proximity to the LV electrode. Accordingly, no rel-
evant change in RAI was detected during the ventricular systole.
Given the above, the systolic decrease in LVI cannot be
explained by a shortening of the interelectrode distance in the
impedance recording dipole, which can only occur when the refer-
ence electrode is put on the right, not on the left side, of the
thorax. In addition, the amplitude of LVI excursion, which was
close to 100 V in some cases, would hardly be justiﬁed by any
electrode movement. An alternative mechanism that could be con-
sidered is related to the blood ﬂow in the cardiac veins. During LV
contraction, the myocardial vein branches are squeezed and blood
is pushed toward the epicardial veins and the coronary sinus, tran-
siently increasing their congestion. If draining is hampered by the
presence of the pacing lead, the blood content of the implanted
vein will be increased as long as myocardial contraction is in pro-
gress, thus creating the physical basis for a local reduction in elec-
tric impedance. Even in partially occluded veins, a small leak of
blood could be sufﬁcient to produce big impedance changes on
both the tip and ring electrodes. Furthermore, the impedance
could be affected by blood reﬂow from the coronary sinus. The
increase in LVI amplitude during isoproterenol administration
could well reﬂect an enhanced coronary perfusion, due to the
vasodilating effects of b-adrenergic stimulation coupled with
increased cardiac metabolism. Accordingly, the inﬂuence of cycle
length on LVI amplitude could be explained by the relationship
between diastolic perfusion time and the amount of blood
stored in the myocardial vein branches at the systole onset. In
chronic LV implants, thrombosis might possibly develop in the
occluded vein and stop the local blood ﬂow, which would result
in a drastic depression of LVI ﬂuctuation. However, in our experi-
ence, all cases featuring the LVI signal on implantation still showed
the same kind of waveform 3 months later. Though a marked
amplitude reduction was noticed in some patients, the signal was
actually strengthened in others, so that no signiﬁcant difference
with the acute recordings was demonstrated in the group.
Potential clinical implications
The application of impedance measurements as a potential tool to
gain information on haemodynamic function is stimulating increasing
interest. A reduction in intrathoracic impedance, derived between
the can of an implanted deﬁbrillator and the lead coil, is considered
an early marker of ﬂuid accumulation in the lungs, allowing timely
medicalcareinacuteheartfailure.
16,17Transthoracicimpedancecar-
diography (IC), performed by a set of surface electrodes applied on
the skin, is used to assess the cardiac output (CO) as a surrogate of
invasivehaemodynamictechniques,andhasbeenproposedasaprac-
tical tool to tailor the timing of BiV pacing in each single patient.
18,19
However, a poor correlation between the optimal interventricular
delay based on IC-CO and LV maximum dP/dt was demonstrated
in a recent study.
20 A positive correlation between LV impedance
ﬂuctuation and stroke volume and a negative correlation between
diastolic impedance and pressure have been reported in animal
experiments using LV electrodes placed on the epicardial surface,
outside the cardiac veins.
21–23 In other studies, quadripolar
systems involving transvenous LV leads have been applied for impe-
dance recording between RV and LV.
24,25 In these cases, however, it
is impossible to tell if the transventricular impedance signal reﬂects
the activity of the LV, RV, or both. The present study demonstrates
that impedance changes of opposite sign can be detected at the
sametime intheRVandLV,respectively,withendocardialand trans-
venouselectrodes.Therelativecontributionofeachelectrodetothe
overall transventricular impedance depends on the distribution of
the electric ﬁeld in the conducting volume. With a bipolar system,
wherethesameelectrodedipolewasusedforbothcurrentinjection
and voltage sampling, the transventricular impedance waveform fully
corresponded to the algebric sum of the separate waveforms
recorded in the RV and LV, the resulting signal resembling the
largest of the two components, but with reduced amplitude.
26
Even if the mechanism underlying the LVI signal is not fully estab-
lished, the waveform time course seems to provide consistent indi-
cations on the timing of LV systole and diastole in a portion of the
LV myocardium larger than the area directly involved in electrical
sensing and stimulation. In this respect, it is noteworthy that the
LVI decrease induced by unilateral RV pacing could start before
the R-wave detection in the LV. The LVI duration could be pro-
posed as a measure of mechanical activity dispersion in the LV
area involved in the signal generation, which might possibly corre-
spond to the myocardial region tributary of the implanted cardiac
vein. However, some caution is advisable, because the LVI reversal
time can be shortened within a few hours after implantation, as if
some elastic phenomena present in acute conditions were
removed or reduced with the progress of time. The comparative
evaluation of the TVI and LVI time course might provide infor-
mation on the lag between RV and LV contraction and relaxation,
potentially useful for appropriate setting of AV and VV delay. In our
opinion, TVI should be more suitable than LVI for permanent
haemodynamic monitoring, as cardiac volume changes are better
detected by impedance recording with endocardial electrodes.
M. Taborsky et al. 538Limitations
The present study provides preliminary information on the impe-
dance ﬂuctuation detected by a coronary sinus lead electrode.
The signal time course suggests a possible relationship with the
timing of LV contraction, which has not yet been directly con-
ﬁrmed and will be the subject of further research. A method to
set the stimulation timing aimed at the synchronization of TVI
and LVI waveforms can be envisaged, but the analysis of its clinical
value was beyond the limit of the present study.
As the LVI signal as described in the present paper is typically
recorded with transvenous electrodes positioned in a posterolat-
eral cardiac vein, which is the ﬁrst choice in coronary lead place-
ment but cannot be obtained in all the implantations, LVI
recording and evaluation might not be useful in all cardiac resyn-
chronization therapy patients.
Conclusions
The present study suggests that LVI could be a valuable tool to
assess the timing of LV mechanical activation. Further work is
required to conﬁrm the correspondence of LVI indications with
haemodynamic and echocardiographic markers of LV systole and
diastole, and to better understand the physiological mechanisms
underlying the LVI ﬂuctuation along the cardiac cycle.
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